U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
NAVIVUMAB
INN   WHO-DD  
INN  
Official Name English
navivumab [INN]
Preferred Name English
Navivumab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(INFLUENZA A VIRUS HEMAGGLUTININ HA) (HUMAN MONOCLONAL CT-P23 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CT-P23 LIGHT CHAIN, DIMER
Common Name English
Code System Code Type Description
FDA UNII
T03CDT3SDM
Created by admin on Mon Mar 31 23:30:48 GMT 2025 , Edited by admin on Mon Mar 31 23:30:48 GMT 2025
PRIMARY
SMS_ID
300000021867
Created by admin on Mon Mar 31 23:30:48 GMT 2025 , Edited by admin on Mon Mar 31 23:30:48 GMT 2025
PRIMARY
INN
9976
Created by admin on Mon Mar 31 23:30:48 GMT 2025 , Edited by admin on Mon Mar 31 23:30:48 GMT 2025
PRIMARY
NCI_THESAURUS
C170203
Created by admin on Mon Mar 31 23:30:48 GMT 2025 , Edited by admin on Mon Mar 31 23:30:48 GMT 2025
PRIMARY
CAS
1443004-16-7
Created by admin on Mon Mar 31 23:30:48 GMT 2025 , Edited by admin on Mon Mar 31 23:30:48 GMT 2025
PRIMARY
ACTIVE MOIETY
NAVIVUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966